The PharmaTimes head-to-head debate between Dr Ben Goldacre and Stephen Whitehead is now available on our website.

The video, shot during the debate at the Royal Institution last month, shows the author of Bad Science and Bad Pharma debate the notion ‘Pharma is not getting its act together’ with the chief executive of the ABPI.

Supporting Dr Goldacre on the panel was Dr Fiona Godlee, editor-in-chief of the British Medical Journal and Sir Iain Chalmers, co-founder of The Cochrane Collaboration.

On Whitehead’s table was Dr Beat Widler, CQA and Quality Risk Management expert and managing partner at Widler & Schiemann; and Dr Richard Tiner, formerly president of the Faculty of Pharmaceutical Medicine (2009-12) and ABPI medical director (1996-2009).

Dr Phil Hammond, GP and Private Eye and PharmaTimes Magazine regular, moderated the event.

The video and debate come at a timely juncture as the ‘juggernaut’ of the AllTrials campaign continues with GlaxoSmithKline, NICE and the British Medical Association all signing up for greater clinical trial transparency.

The debate, which became heated at points, saw Whitehead describe AllTrials as nothing more than a “PR initiative”, something Goldacre has severely criticised.

To see the debate and keep informed on the most important topics for pharma in 2013 completely free, please visit:

PharmaTimes will be running an in-depth feature on the event on our April edition, with extra comment on next steps for transparency. Not a subscriber? Then to see this and more, please visit our subscription page: